At Tabula Rasa HealthCare (TRHC), Kevin Boesen, Pharm.D., has been appointed chief sales officer. In his new role Boesen will be responsible for all direct and channel sales efforts in the United States and Canada, with a focus on expanding the adoption of the company’s signature product, MedWise, into health plans and healthcare systems, programs of all-inclusive care for the elderly, and other financially at-risk healthcare organizations.
Boesen was the founder and CEO of SinfoniaRx, which was acquired by Tabula Rasa HealthCare in 2017. He brings more than 15 years of experience in healthcare sales, including healthcare information technology solutions and services. He built SinfoniaRx into one of the largest medication therapy management platform companies in the United States. SinfoniaRx provides medication management services for more that 450 health plans, representing more than 10 million patients, including 8 million Medicare beneficiaries. SinfoniaRx’s technology is also integrated with thousands of community pharmacies.
Boesen says he has seen great opportunities to help current and new health plan clients enhance quality and reduce costs through the use of Tabula Rasa’s technology platforms. “The problem we are addressing is adverse drug events, the fourth leading cause of death in the United States.” The various TRHC sales functions will be expanded for future growth and new markets under Boesen’s leadership. To assure a smooth transition, Sandra Leal, Pharm.D., and COO of SinfoniaRx, will assume the role of CEO of SinfoniaRx.